Kodiak Sciences Inc. (Nasdaq: KOD), today announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer in patients with diabetic retinopathy ("DR").

Diabetes can affect many parts of the body, including the eyes. Routine eye exams can help identify the early stages of eye ...

Usha (name changed), 62, was experiencing sudden and painless loss of vision in the right eye for one day when she turned up ...

Kodiak Sciences (KOD) announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer in patients with ...

HealthTree Foundation, a global nonprofit dedicated to improving outcomes for blood cancer patients through technology-driven solutions, announces the launch of its new HealthTree mobile app. Designed ...

Azenta, Inc. announced that Lawrence Y. Lin, Executive Vice President and Chief Financial Officer, will participate in the Virtual KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025 ...

REGENXBIO Inc. (Nasdaq: RGNX) today announced new interim biomarker data from the Phase I/II portion of the AFFINITY DUCHENNE® trial of RGX-202 for the treatment of Duchenne muscular dystrophy will be ...

Jones Financial Companies Lllp increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) ...

A new stem cell therapy is giving hope to patients with serious cornea injuries. This breakthrough treatment could revolutionize eye health.

A just-launched ophthalmology practice has opened in a newly purchased medical office building in Massapequa. NY Retina, ...

Urquhart Opticians has taken another leap forward in eye care by introducing ground-breaking new technology in its Ayr and Kilmarnock practices.